{
  "company": {
    "name": "Asgard Therapeutics",
    "website": "https://asgardthx.com/",
    "record": "https://startuphistory.org/c/asgardthx.com"
  },
  "status": null,
  "history_since": "2019-08-26T09:36:53.000Z",
  "baseline": {
    "snapshot_id": "9aa9f57226af1dc61231d9da91908b5fbef9ee7a8f9952917dd9a4323d67fb84",
    "observed_at": "2019-08-26T09:36:53.000Z",
    "headline": "Developing a cancer immunotherapy based on direct cell reprogramming",
    "description": null,
    "evidence": "https://web.archive.org/web/20190826093653/http://asgardthx.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T11:30:16.039Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-05T11:30:16.039Z",
      "variants": [
        {
          "headline": "Developing a cancer immunotherapy based on direct cell reprogramming",
          "subhead": null,
          "observed_at": "2019-08-26T09:36:53.000Z",
          "evidence": "https://web.archive.org/web/20190826093653/http://asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ASGARD THERAPEUTICS – Developing a cancer immunotherapy based on direct cell reprogramming",
          "subhead": null,
          "observed_at": "2020-08-05T19:26:00.000Z",
          "evidence": "https://web.archive.org/web/20200805192600/http://asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ASGARD THERAPEUTICS – Developing a cancer immunotherapy based on direct cell reprogramming",
          "subhead": null,
          "observed_at": "2021-01-25T10:32:32.000Z",
          "evidence": "https://web.archive.org/web/20210125103232/http://asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "ASGARD THERAPEUTICS – Developing a cancer immunotherapy based on direct cell reprogramming",
          "subhead": null,
          "observed_at": "2022-01-20T19:15:29.000Z",
          "evidence": "https://web.archive.org/web/20220120191529/https://asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reprogramming is the next leap forward in cancer immunotherapy",
          "subhead": null,
          "observed_at": "2022-08-13T05:24:41.000Z",
          "evidence": "https://web.archive.org/web/20220813052441/https://www.asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reprogramming is the next leap forward in cancer immunotherapy",
          "subhead": null,
          "observed_at": "2023-09-29T06:31:26.000Z",
          "evidence": "https://web.archive.org/web/20230929063126/https://www.asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reprogramming is the next leap forward in cancer immunotherapy",
          "subhead": null,
          "observed_at": "2024-01-04T04:22:30.000Z",
          "evidence": "https://web.archive.org/web/20240104042230/https://www.asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reprogramming is the next leap forward in cancer immunotherapy",
          "subhead": null,
          "observed_at": "2025-01-01T08:54:59.000Z",
          "evidence": "https://web.archive.org/web/20250101085459/https://www.asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reprogramming is the next leap forward in cancer immunotherapy",
          "subhead": null,
          "observed_at": "2025-07-13T19:41:09.000Z",
          "evidence": "https://web.archive.org/web/20250713194109/https://www.asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reprogramming is the next leap forward in cancer immunotherapy",
          "subhead": null,
          "observed_at": "2025-10-12T03:15:14.000Z",
          "evidence": "https://web.archive.org/web/20251012031514/https://www.asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reprogramming is the next leap forward in cancer immunotherapy",
          "subhead": null,
          "observed_at": "2026-08-26T07:07:13.000Z",
          "evidence": "https://web.archive.org/web/20260826070713/https://www.asgardthx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Reprogramming is the next leap forward in cancer immunotherapy",
          "subhead": null,
          "observed_at": "2026-11-05T11:30:16.039Z",
          "evidence": "https://www.asgardthx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Reprogramming is the next leap forward in cancer immunotherapy",
      "subhead": null,
      "from": "2019-08-26T09:36:53.000Z",
      "to": "2026-11-05T11:30:16.039Z",
      "captures": 12,
      "evidence": "https://www.asgardthx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2019-08-26T09:36:53.000Z",
          "to": "2026-11-05T11:30:16.039Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-327711e79702a8283d22a021425359645d66c13fd6baf34a9a41e84cafdd68a9:05ed0aac94e6fe990e247d75311b09d9a928fe3699cc52345e09d9c347511206:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20210125103232/http://asgardthx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2021-01-25T10:32:32.000Z",
        "to": "2022-01-20T19:15:29.000Z"
      },
      "evidence": "https://web.archive.org/web/20220120191529/https://asgardthx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Asgard Therapeutics” company record, https://startuphistory.org/c/asgardthx.com"
}